RU2006123590A - METHOD FOR TREATING SECONDARY IMMUNO DEFICIENCY IN CHILDREN IN THE POST-OPERATIVE PERIOD IN SEVERE CRANIO-BRAIN INJURY COMBINED WITH INJURIES TO THE MOTOR-MOTOR APPARATUS - Google Patents

METHOD FOR TREATING SECONDARY IMMUNO DEFICIENCY IN CHILDREN IN THE POST-OPERATIVE PERIOD IN SEVERE CRANIO-BRAIN INJURY COMBINED WITH INJURIES TO THE MOTOR-MOTOR APPARATUS Download PDF

Info

Publication number
RU2006123590A
RU2006123590A RU2006123590/14A RU2006123590A RU2006123590A RU 2006123590 A RU2006123590 A RU 2006123590A RU 2006123590/14 A RU2006123590/14 A RU 2006123590/14A RU 2006123590 A RU2006123590 A RU 2006123590A RU 2006123590 A RU2006123590 A RU 2006123590A
Authority
RU
Russia
Prior art keywords
motor
injuries
children
brain injury
severe
Prior art date
Application number
RU2006123590/14A
Other languages
Russian (ru)
Other versions
RU2355419C2 (en
Inventor
Лариса Романовна Чардымова (RU)
Лариса Романовна Чардымова
Андрей Данилович Лазарь (RU)
Андрей Данилович Лазарь
В чеслав Владимирович Паршиков (RU)
Вячеслав Владимирович Паршиков
Original Assignee
Государственное образовательное учреждение высшего профессионального образовани "Нижегородска государственна медицинска академи Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НижГМА Росздрава) (RU)
Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НижГМА Росздрава)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное образовательное учреждение высшего профессионального образовани "Нижегородска государственна медицинска академи Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НижГМА Росздрава) (RU), Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НижГМА Росздрава) filed Critical Государственное образовательное учреждение высшего профессионального образовани "Нижегородска государственна медицинска академи Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НижГМА Росздрава) (RU)
Priority to RU2006123590/14A priority Critical patent/RU2355419C2/en
Publication of RU2006123590A publication Critical patent/RU2006123590A/en
Application granted granted Critical
Publication of RU2355419C2 publication Critical patent/RU2355419C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (1)

Способ лечения вторичного иммунодефицита у детей при тяжелой черепно-мозговой травме, сочетанной с повреждениями опорно-двигательного аппарата, включающий введение медикаментозного средства, отличающийся тем, что в качестве медикаментозного средства используют церулоплазмин, который вводят в суточной разовой дозе 6-8 мг/кг массы тела, в зависимости от возраста ребенка, на 200 мл 0,9%-ного раствора хлорида натрия внутривенно капельно со скоростью 20-25 капель в минуту в течение не менее 12 дней.A method of treating secondary immunodeficiency in children with severe traumatic brain injury, combined with injuries of the musculoskeletal system, comprising administering a medicament, characterized in that ceruloplasmin is used as a medicament, which is administered in a single daily dose of 6-8 mg / kg of body weight body, depending on the age of the child, per 200 ml of 0.9% sodium chloride solution intravenously at a rate of 20-25 drops per minute for at least 12 days.
RU2006123590/14A 2006-07-03 2006-07-03 Method of treating secondary immunodeficiency in children in post-operative period in case of severe craniocerebral injury, combined with injuries of musculo-sckeletal system RU2355419C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2006123590/14A RU2355419C2 (en) 2006-07-03 2006-07-03 Method of treating secondary immunodeficiency in children in post-operative period in case of severe craniocerebral injury, combined with injuries of musculo-sckeletal system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006123590/14A RU2355419C2 (en) 2006-07-03 2006-07-03 Method of treating secondary immunodeficiency in children in post-operative period in case of severe craniocerebral injury, combined with injuries of musculo-sckeletal system

Publications (2)

Publication Number Publication Date
RU2006123590A true RU2006123590A (en) 2008-01-20
RU2355419C2 RU2355419C2 (en) 2009-05-20

Family

ID=39108023

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006123590/14A RU2355419C2 (en) 2006-07-03 2006-07-03 Method of treating secondary immunodeficiency in children in post-operative period in case of severe craniocerebral injury, combined with injuries of musculo-sckeletal system

Country Status (1)

Country Link
RU (1) RU2355419C2 (en)

Also Published As

Publication number Publication date
RU2355419C2 (en) 2009-05-20

Similar Documents

Publication Publication Date Title
WO2007136518A3 (en) Treatment of autoimmune disorders
AR082150A1 (en) N-ETIL-N-Phenyl-1,2-DIHIDRO-4-HYDROXI-5-CHLORINE-1-METHYL-2-OXOQUINOLIN-3-CARBOXAMIDE DEUTERADA, SALTS AND USES OF THE SAME, TREATMENT METHOD, COMPOUND BLEND, COMPOSITION PHARMACEUTICS, PREPARATION PROCESS, ENRICHED COMPOUND WITH DEUTERIO
RS52471B (en) Dosage regimen for the treatment of a traumatic brain injury with progesterone
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
PH12014502447A1 (en) Use of high dose laquinimod for treating multiple sclerosis
EP2039686A4 (en) Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases
WO2007087241A3 (en) Treatment of ischemic disease using thrombopoietin
HRP20171742T4 (en) 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide for the treatment of migraine via the oral or intravenous route
KR20140025314A (en) A combination composition
UA98462C2 (en) Methods for treating autoimmune diseases using a taci-ig fusion molecule
MX2007004104A (en) Use of lavender oil for the prophylaxis and treatment of neuro asthenia, somatization disorders and other diseases associated with stress.
BR0116653A (en) Medicinal product containing a polyamine as active substance
AR054210A1 (en) USE OF ALFA-1 ANTITRIPSIN FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF FIBROMIALGIA
RU2006123590A (en) METHOD FOR TREATING SECONDARY IMMUNO DEFICIENCY IN CHILDREN IN THE POST-OPERATIVE PERIOD IN SEVERE CRANIO-BRAIN INJURY COMBINED WITH INJURIES TO THE MOTOR-MOTOR APPARATUS
CN101450048B (en) Acute hypoxia injury resistance use of teprenone
IL151627A0 (en) Divided dose therapies with vascular damaging activity
Kondo et al. Anti-tumor activity of pamidronate in human multiple myeloma
MX2021007324A (en) Oral therapy using 6,8-bis-benzylthio-octanoic acid.
EP3265076A1 (en) New use of acetylsalicylic acid and derivatives thereof
Sivkova et al. Optimization of treatment focal forms of epilepsy in young children
NZ599227A (en) Therapeutic agent for chronic pain
RU2007100833A (en) METHOD FOR TREATING INFECTIOUS FACILITY OF THE FACIAL NERVE IN THE ACUTE PERIOD
Sasson Nausea: case report
Rossetti Single-shot vs conventional therapy with amikacin for treatment of uncomplicated urinary tract infections: a multicenter study
Fond Quetiapine/zuclopenthixol interaction

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20090228